Surfactant protein A (SP-A) inhibits agglomeration and macrophage uptake of toxic amine modified nanoparticles

References

• Bakshi MS, Zhao L, Smith R, Possmayer F, Petersen NO. 2008. Metal nanoparticle pollutants interfere with pulmonary surfactant function in vitro. Biophys J 94:855–68
   PubMed Web of Science ®Google Scholar
• Barran-Berdon AL, Pozzi D, Caracciolo G, Capriotti AL, Caruso G, Cavaliere C, et al. 2013. Time evolution of nanoparticle-protein corona in human plasma: relevance for targeted drug delivery. Langmuir 29:6485–94
   PubMed Web of Science ®Google Scholar
• Borron P, Mcintosh JC, Korfhagen TR, Whitsett JA, Taylor J, Wright JR. 2000. Surfactant-associated protein a inhibits lps-induced cytokine and nitric oxide production in vivo. Am J Physiol Lung Cell Mol Physiol 278:L840–7
   PubMed Web of Science ®Google Scholar
• Borron P, Veldhuizen RA, Lewis JF, Possmayer F, Caveney A, Inchley K, et al. 1996. Surfactant associated protein-A inhibits human lymphocyte proliferation and Il-2 production. Am J Respir Cell Mol Biol 15:115–21
   PubMed Web of Science ®Google Scholar
• Borron PJ, Crouch EC, Lewis JF, Wright JR, Possmayer F, Fraher LJ. 1998. Recombinant rat surfactant-associated protein D inhibits human T lymphocyte proliferation and Il-2 production. J Immunol 161:4599–603
   PubMed Web of Science ®Google Scholar
• Brinker KG, Garner H, Wright JR. 2003. Surfactant protein A modulates the differentiation of murine bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 284:L232–41
   PubMed Web of Science ®Google Scholar
• Clark H, Palaniyar N, Strong P, Edmondson J, Hawgood S, Reid KB. 2002. Surfactant protein D reduces alveolar macrophage apoptosis in vivo. J Immunol 169:2892–9
   PubMed Web of Science ®Google Scholar
• Deng ZJ, Liang M, Toth I, Monteiro MJ, Minchin RF. 2012. Molecular interaction of poly(acrylic acid) gold nanoparticles with human fibrinogen. Acs Nano 6:8962–9
   PubMed Web of Science ®Google Scholar
• Erpenbeck VJ, Malherbe DC, Sommer S, Schmiedl A, Steinhilber W, Ghio AJ, et al. 2005. Surfactant protein D increases phagocytosis and aggregation of pollen-allergen starch granules. Am J Physiol Lung Cell Mol Physiol 288:L692–8
   PubMed Web of Science ®Google Scholar
• Gasser M, Wick P, Clift MJ, Blank F, Diener L, Yan B, et al. 2012. Pulmonary surfactant coating of multi-walled carbon nanotubes (Mwcnts) influences their oxidative and pro-inflammatory potential in vitro. Part Fibre Toxicol 9:17
   PubMed Web of Science ®Google Scholar
• Geiser M, Casaulta M, Kupferschmid B, Schulz H, Semmler-Behnke M, Kreyling W. 2008. The role of macrophages in the clearance of inhaled ultrafine titanium dioxide particles. Am J Respir Cell Mol Biol 38:371–6
   PubMed Web of Science ®Google Scholar
• Haagsman HP, Sargeant T, Hauschka PV, Benson BJ, Hawgood S. 1990. Binding of calcium to sp-A, a surfactant-associated protein. Biochemistry 29:8894–900
   PubMed Web of Science ®Google Scholar
• Hansen S, Lo B, Evans K, Neophytou P, Holmskov U, Wright JR. 2007. Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens. Am J Respir Cell Mol Biol 36:94–102
   PubMed Web of Science ®Google Scholar
• Hartshorn KL, Crouch EC, White MR, Eggleton P, Tauber AI, Chang D, Sastry K. 1994. Evidence for a protective role of pulmonary surfactant protein D (Sp-D) against influenza A viruses. J Clin Invest 94:311–19
   PubMed Web of Science ®Google Scholar
• Hawgood S, Brown C, Edmondson J, Stumbaugh A, Allen L, Goerke J, et al. 2004. Pulmonary collectins modulate strain-specific influenza A virus infection and host responses. J Virol 78:8565–72
   PubMed Web of Science ®Google Scholar
• Head JF, Mealy TR, Mccormack FX, Seaton BA. 2003. Crystal structure of trimeric carbohydrate recognition and neck domains of surfactant protein A. J Biol Chem 278:43254–60
   PubMed Web of Science ®Google Scholar
• Kendall M. 2007. Fine airborne urban particles (Pm2.5) sequester lung surfactant and amino acids from human lung lavage. Am J Physiol Lung Cell Mol Physiol 293:L1053–8
   PubMed Web of Science ®Google Scholar
• Kendall M, Brown L, Trought, K. 2004. Molecular adsorption at particle surfaces: a Pm toxicity mediation mechanism. Inhal Toxicol 16:99–105
   PubMed Web of Science ®Google Scholar
• Kendall M, Ding P, Mackay RM, Deb R, McKenzie Z, Kendall K, Madsen J, Clark H. 2013. Surfactant protein D (Sp-D) alters cellular uptake of particles and nanoparticles. Nanotoxicology 7:963–73
   PubMed Web of Science ®Google Scholar
• Kendall M, Holgate S. 2012. Health impact and toxicological effects of nanomaterials in the lung. Respirology 17:743–58
   PubMed Web of Science ®Google Scholar
• Kendall M, Tetley TD, Wigzell E, Hutton B, Nieuwenhuijsen M, Luckham P. 2002. Lung lining liquid modifies Pm(2.5) in favor of particle aggregation: a protective mechanism. Am J Physiol Lung Cell Mol Physiol 282:L109–14
   PubMed Web of Science ®Google Scholar
• Levine AM, Bruno MD, Huelsman KM, Ross GF, Whitsett JA, Korfhagen TR. 1997. Surfactant protein A-deficient mice are susceptible to group B Streptococcal infection. J Immunol 158:4336–40
   PubMed Web of Science ®Google Scholar
• Levine AM, Gwozdz J, Stark J, Bruno M, Whitsett J, Korfhagen T. 1999a. Surfactant protein-A enhances respiratory syncytial virus clearance in vivo. J Clin Invest 103:1015–21
   PubMed Web of Science ®Google Scholar
• Levine AM, Hartshorn K, Elliott J, Whitsett J, Korfhagen T. 2002. Absence of Sp-A modulates innate and adaptive defense responses to pulmonary influenza infection. Am J Physiol Lung Cell Mol Physiol 282:L563–72
   PubMed Web of Science ®Google Scholar
• Levine AM, Kurak KE, Bruno MD, Stark JM, Whitsett JA, Korfhagen TR. 1998. Surfactant protein-A-deficient mice are susceptible to Pseudomonas aeruginosa infection. Am J Respir Cell Mol Biol 19:700–8
   PubMed Web of Science ®Google Scholar
• Levine AM, Kurak KE, Wright JR, Watford WT, Bruno MD, Ross GF, et al. 1999b. Surfactant protein-A binds group B Streptococcus enhancing phagocytosis and clearance from lungs of surfactant protein-A-deficient mice. Am J Respir Cell Mol Biol 20:279–86
   PubMed Web of Science ®Google Scholar
• Levine AM, Whitsett JA. 2001. Pulmonary collectins and innate host defense of the lung. Microbes Infect 3:161–6
   PubMed Web of Science ®Google Scholar
• Li G, Siddiqui J, Hendry M, Akiyama J, Edmondson J, Brown C, et al. 2002. Surfactant protein-A-deficient mice display an exaggerated early inflammatory response to a beta-resistant strain of influenza A virus. Am J Respir Cell Mol Biol 26:277–82
   PubMed Web of Science ®Google Scholar
• López-Sánchez A, Sáenz A, Casals C. 2011. Surfactant protein A (Sp-A)-tacrolimus complexes have a greater anti-inflammatory effect than either Sp-A or tacrolimus alone on human macrophage-like U937 cells. Eur J Pharm Biopharm 77:384–91
   PubMed Web of Science ®Google Scholar
• McKenzie Z, Kendall M, Mackay R-M, Tetley T, Morgan C, Mark G, et al. 2015. Nanoparticles modulate surfactant protein A and D mediated protection against influenza A infection in vitro. Philos Trans R Soc Lond B Biol Sci 370:20140049
   Google Scholar
• Muhlfeld C, Rothen-Rutishauser B, Blank F, Vanhecke D, Ochs M, Gehr P. 2008. Interactions of nanoparticles with pulmonary structures and cellular responses. Am J Physiol Lung Cell Mol Physiol 294:L817–29
   PubMed Web of Science ®Google Scholar
• Nanotechnologies TPOE. 2014. Consumer products inventory [Online]. Nanotechnology. Available at: http://www.Nanotechproject.Org/Cpi/. Accessed on 9 September 2014
   Google Scholar
• Oberdörster G, Maynard A, Donaldson K, Castranova V, Fitzpatrick J, Ausman K, et al. 2005a. Principles for characterizing the potential human health effects from exposure to nanomaterials: elements of a screening strategy. Part Fibre Toxicol 2:8
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Oberdörster E, Oberdörster J. 2005b. Nanotoxicology: an emerging discipline evolving from studies of ultrafine particles. Environ Health Perspect 113:823–39
   PubMed Web of Science ®Google Scholar
• Oberdörster G, Sharp Z, Atudorei V, Elder A, Gelein R, Lunts A, et al. 2002. Extrapulmonary translocation of ultrafine carbon particles following whole-body inhalation exposure of rats. J Toxicol Environ Health A 65:1531–43
   PubMed Web of Science ®Google Scholar
• Palaniyar N, Clark H, Nadesalingam J, Hawgood S, Reid KB. 2003. Surfactant protein D binds genomic DNA and apoptotic cells, and enhances their clearance, in vivo. Ann N Y Acad Sci 1010:471–5
   PubMed Web of Science ®Google Scholar
• Pastva AM, Wright JR, Williams KL. 2007. Immunomodulatory roles of surfactant proteins A and D: implications in lung disease. Proc Am Thorac Soc 4:252–7
   PubMedGoogle Scholar
• Patel II, Steuwe C, Reichelt S, Mahajan S. 2013. Coherent anti-Stokes Raman scattering for label-free biomedical imaging. J Opt 15:094006
   Google Scholar
• Pérez-Gil J. 2008. Structure of pulmonary surfactant membranes and films: the role of proteins and lipid-protein interactions. Biochim Biophys Acta 1778:1676–95
   PubMed Web of Science ®Google Scholar
• Raschke WC, Baird S, Ralph P, Nakoinz I. 1978. Functional macrophage cell lines transformed by abelson leukemia virus. Cell 15:261–7
   PubMed Web of Science ®Google Scholar
• Ruenraroengsak P, Novak P, Berhanu D, Thorley AJ, Valsami-Jones E, Gorelik J, et al. 2012. Respiratory epithelial cytotoxicity and membrane damage (holes) caused by amine-modified nanoparticles. Nanotoxicology 6:94–108
   PubMed Web of Science ®Google Scholar
• Ruge CA, Kirch J, Canadas O, Schneider M, Perez-Gil J, Schaefer UF, et al. 2011. Uptake of nanoparticles by alveolar macrophages is triggered by surfactant protein A. Nanomedicine 7:690–3
   PubMed Web of Science ®Google Scholar
• Ruge CA, Schaefer UF, Herrmann J, Kirch J, Canadas O, Echaide M, et al. 2012. The interplay of lung surfactant proteins and lipids assimilates the macrophage clearance of nanoparticles. PLoS One 7:E40775
   PubMed Web of Science ®Google Scholar
• Salvador-Morales C, Townsend P, Flahaut E, Ve’Nien-Bryan C, Vlandas A, Green MLH, Sim RB. 2007. Binding of pulmonary surfactant proteins to carbon nanotubes; potential for damage to lung immune defense mechanisms. Carbon 45:607–17
   Web of Science ®Google Scholar
• Schleh C, Kreyling WG, Lehr CM. 2013. Pulmonary surfactant is indispensable in order to simulate the in vivo situation. Part Fibre Toxicol 10:6
   PubMed Web of Science ®Google Scholar
• Schulze C, Schaefer UF, Ruge CA, Wohlleben W, Lehr CM. 2011. Interaction of metal oxide nanoparticles with lung surfactant protein A. Eur J Pharm Biopharm 77:376–83
   PubMed Web of Science ®Google Scholar
• Shrive AK, Tharia HA, Strong P, Kishore U, Burns I, Rizkallah PJ, et al. 2003. High-resolution structural insights into ligand binding and immune cell recognition by human lung surfactant protein D. J Mol Biol 331:509–23
   PubMed Web of Science ®Google Scholar
• Suwabe A, Mason RJ, Voelker DR. 1996. Calcium dependent association of surfactant protein A with pulmonary surfactant: application to simple surfactant protein A purification. Arch Biochem Biophys 327:285–91
   PubMed Web of Science ®Google Scholar
• Voss T, Eistetter H, Schafer KP, Engel J. 1988. Macromolecular organization of natural and recombinant lung surfactant protein Sp 28-36. structural homology with the complement factor C1q. J Mol Biol 201:219–27
   PubMed Web of Science ®Google Scholar
• Walkey CD, Olsen JB, Guo H, Emili A, Chan WC. 2012. Nanoparticle size and surface chemistry determine serum protein adsorption and macrophage uptake. J Am Chem Soc 134:2139–47
   PubMed Web of Science ®Google Scholar
• Wright JR, Wager RE, Hawgood S, Dobbs L, Clements JA. 1987. Surfactant apoprotein Mr = 26 000–36 000 enhances uptake of liposomes by type II cells. J Biol Chem 262:2888–94
   PubMed Web of Science ®Google Scholar
• Zelikoff JT, Chen LC, Cohen MD, Fang K, Gordon T, Li Y, et al. 2003. Effects of inhaled ambient particulate matter on pulmonary antimicrobial immune defense. Inhal Toxicol 15:131–50
   PubMed Web of Science ®Google Scholar